- Home
- INBS vs COCP Comparison
INBS vs COCP Comparison
Compare INBS & COCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INBS
- COCP
- Stock Information
- Founded
- INBS 2016
- COCP N/A
- Country
- INBS United States
- COCP United States
- Employees
- INBS N/A
- COCP N/A
- Industry
- INBS Medical Specialities
- COCP Biotechnology: Pharmaceutical Preparations
- Sector
- INBS Health Care
- COCP Health Care
- Exchange
- INBS Nasdaq
- COCP Nasdaq
- Market Cap
- INBS 16.4M
- COCP 15.3M
- IPO Year
- INBS N/A
- COCP N/A
- Fundamental
- Price
- INBS $1.50
- COCP $1.43
- Analyst Decision
- INBS
- COCP Strong Buy
- Analyst Count
- INBS 0
- COCP 1
- Target Price
- INBS N/A
- COCP $7.00
- AVG Volume (30 Days)
- INBS 144.8K
- COCP 17.0K
- Earning Date
- INBS 05-07-2025
- COCP 03-31-2025
- Dividend Yield
- INBS N/A
- COCP N/A
- EPS Growth
- INBS N/A
- COCP N/A
- EPS
- INBS N/A
- COCP N/A
- Revenue
- INBS $3,031,405.00
- COCP N/A
- Revenue This Year
- INBS $280.88
- COCP N/A
- Revenue Next Year
- INBS $126.26
- COCP N/A
- P/E Ratio
- INBS N/A
- COCP N/A
- Revenue Growth
- INBS 23.21
- COCP N/A
- 52 Week Low
- INBS $1.00
- COCP $1.35
- 52 Week High
- INBS $4.09
- COCP $3.26
- Technical
- Relative Strength Index (RSI)
- INBS 32.78
- COCP 34.72
- Support Level
- INBS $1.34
- COCP $1.38
- Resistance Level
- INBS $2.21
- COCP $1.49
- Average True Range (ATR)
- INBS 0.19
- COCP 0.10
- MACD
- INBS -0.08
- COCP -0.00
- Stochastic Oscillator
- INBS 14.68
- COCP 12.82
About INBS Intelligent Bio Solutions Inc.
Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company business through two operating segments include Commercially available Intelligent Fingerprinting Products (IFPG or IFPG segment) and, Development Stage Biosensor Platform Technology (BPT segment).
About COCP Cocrystal Pharma Inc.
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first- and-in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).